6.88 USD
▼-0.17-2.41%
盘后 6.89 +0.15%
2026-09-15
市值
$248.43M
市盈率
—
EPS
-3.97
股息率
—
52 周区间
5.02 – 16.45
成交量
247.69K
Beta
-0.25
目标价
19.00
52W 低 5.0252W 高 16.45
价格走势
公司简介
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company’s Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was f...